Axsome Therapeutics, Inc. (AXSM)
188.99
+4.80
(+2.61%)
USD |
NASDAQ |
Apr 17, 16:00
186.00
-2.99
(-1.58%)
After-Hours: 20:00
Axsome Therapeutics SG&A Expense (Quarterly) : 169.30M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 155.62M |
| Madrigal Pharmaceuticals, Inc. | 239.98M |
| Insmed, Inc. | 212.48M |
| Apellis Pharmaceuticals, Inc. | 147.10M |
| Precision BioSciences, Inc. | 7.232M |